Echo(cardiography) in a first-line and second-line approach

被引：0
|
作者：
Garretsen, JW [1 ]
机构：
[1] Specialist Dierenklin, Vet Specialist Ctr De Wagenrenk, Utrecht, Netherlands
来源：
TIJDSCHRIFT VOOR DIERGENEESKUNDE | 1998年 / 123卷 / 20期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：592 / 593
页数：2
相关论文
共 50 条
  • [21] Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases
    Liefferinckx, Claire
    Verstockt, Bram
    Gils, Ann
    Tops, Sophie
    Van Moerkercke, Wouter
    Vermeire, Severine
    Franchimont, Denis
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (06) : 750 - 758
  • [22] Second-Line Therapy for Patients With Chronic Myeloid Leukemia Resistant to First-Line Imatinib
    Lau, Anna
    Seiter, Karen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (03): : 186 - 196
  • [23] Incidence of First-Line and Second-Line Myelodysplastic Syndrome in a US Commercial Claims Database
    Cogle, Christopher R.
    Kurtin, Sandra E.
    Bentley, Tanya G. K.
    Broder, Michael S.
    Chang, Eunice
    Lawrence, Moira E.
    McKearn, Thomas J.
    Megaffin, Scott
    Percy, Rita
    Petrone, Michael E.
    Sun, Gordon H.
    BLOOD, 2014, 124 (21)
  • [24] Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis
    Piccirillo, JF
    Mager, DE
    Frisse, ME
    Brophy, RH
    Goggin, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (15): : 1849 - 1856
  • [25] Changes of Eradication rates of first-line and second-line therapy for Helicoabacter pylori infection
    Kim, G.
    Kim, Y.
    Song, J.
    Park, S.
    HELICOBACTER, 2010, 15 (04) : 341 - 341
  • [26] CHANGES OF ERADICATION RATES OF FIRST-LINE AND SECOND-LINE THERAPY FOR HELICOABACTER PYLORI INFECTION
    Park, S.
    HELICOBACTER, 2015, 20 : 96 - 96
  • [27] Comparison of the acid inhibitors in first-line and second-line treatment of Helicobacter pylori infection
    Tanabe, Hiroki
    Ando, Katsuyoshi
    Sato, Kiichi
    Ohta, Katsuhisa
    Ichiishi, Eiichiro
    Otake, Takaaki
    Kohgo, Yutaka
    Fujiya, Mikihiro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 64 - 65
  • [28] Outcome of Second-Line Treatment After First-Line Chemotherapy With the GONO FOLFOXIRI Regimen
    Fornaro, Lorenzo
    Vasile, Enrico
    Masi, Gianluca
    Loupakis, Fotios
    Baldi, Giacomo Giulio
    Allegrini, Giacomo
    Salvatore, Lisa
    Cremolini, Chiara
    Cupini, Samanta
    Cortesi, Enrico
    Tuzi, Alessandro
    Granetto, Cristina
    Brunetti, Isa Maura
    Ricci, Sergio
    Falcone, Alfredo
    CLINICAL COLORECTAL CANCER, 2012, 11 (01) : 71 - 76
  • [29] Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment
    Vashist, Yogesh
    Aigner, Kornelia
    Dam, Miriam
    Gailhofer, Sabine
    Aigner, Karl R.
    CURRENT ONCOLOGY, 2022, 29 (07) : 4868 - 4878
  • [30] Comprehensive analysis of lung adenocarcinoma patients with gefitinib as first-line, second-line and third-line treatment
    Liu, Daoming
    Wang, Fei
    Chen, Xia
    Shi, Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 20171 - 20178
12345